Investor Presentaiton slide image

Investor Presentaiton

41 Patient achieved complete histological remission with oral Rigosertib Baseline 200 m Cycle 4 Cycle 6 SCC, invasive SCC, resolving superficial Scar Banner, et al. poster 613, ISID 2023 ONCONOVA THERAPEUTICS
View entire presentation